Company profile
electroCore, Inc.
NASDAQ: ECOR · Healthcare · Medical - Devices
#495 of 1,422 Healthcare companies by revenue70th-percentile growth
EA Score
57CFH 43DQ 68GM 76SS 54
v0.1 · 65/100 weight · provisional
↑ filing timeliness, 3-yr revenue growth · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$34.9M
Rev growth YoY (TTM)
+31.9%
Net income (FY)
-$14.0M
Employees
83
as of 2026-08-19
Market cap
$92.6M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$32.0M$32.0M2025
Net income-$14.0M-$14.0M2025
Operating income-$13.2M-$13.2M2025
Total assets$18.7M$18.7M2025
Liabilities$20.4M$20.4M2025
Equity-$1.7M-$1.7M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is electroCore, Inc.’s revenue?
electroCore, Inc. booked $32.0M in FY2025 revenue, growing 27% year over year — faster than most Healthcare companies we track, at a -43.6% net margin.
Peers · Healthcare
Stereotaxis, Inc.55CAoxing Pharmaceutical Company, Inc.——MediPharm Labs Corp.61CNova Leap Health Corp.75B+Sonendo, Inc.——Cryo-Cell International, Inc.63CNeighbors
Morris →Key facts
CEOThomas J. Errico
SectorHealthcare
IndustryMedical - Devices
HeadquartersRockaway, NJ
ExchangeNASDAQ: ECOR
Employees83
IPO date2018-06-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.